Laser Therapy (LLLT): How Cold Laser and Photobiomodulation Work and What They Treat

Of all the therapies we cover on Regenerated, laser therapy might be the one with the widest gap between its scientific credibility and public awareness. While most people have never heard of photobiomodulation – or dismiss “cold laser” as something vaguely woo-woo – researchers have published over 6,000 peer-reviewed studies on the topic, the FDA has cleared multiple LLLT devices for specific conditions, and the underlying mechanism of action (light stimulating mitochondrial function) is well-characterized at the molecular level.

The basic premise is almost disarmingly simple: specific wavelengths of light, delivered at the right dose, stimulate your cells to produce more energy and repair themselves more efficiently. No heat, no tissue destruction, no drugs – just photons activating the cellular machinery that evolution has been fine-tuning for billions of years. The challenge has always been separating the solid science from the marketing hype, because both exist in abundance. Let’s do exactly that.

How Light Heals: The Mechanism of Photobiomodulation

To understand why shining a specific color of light on tissue would have any biological effect at all, you need to understand one key enzyme: cytochrome c oxidase (also called Complex IV). This enzyme sits inside your mitochondria – the energy-producing organelles in every cell – and plays a critical role in the electron transport chain that produces ATP, your cells’ universal energy currency.

Wavelengths Matter: Red vs. Near-Infrared

Not just any light works. The biological effects of photobiomodulation depend on using wavelengths within what scientists call the “optical window” – the range where light can penetrate tissue and be absorbed by chromophores (light-absorbing molecules) like cytochrome c oxidase:

Red light (630-670nm): Penetrates approximately 1-2 cm into tissue. Absorbed strongly by cytochrome c oxidase. Best for superficial conditions – skin wounds, oral mucositis, surface-level inflammation, dermatological conditions, and hair follicle stimulation. The 630-660nm range is the most commonly used and studied for superficial applications.

Near-infrared (NIR) light (810-850nm): Penetrates deeper – approximately 3-5 cm, reaching muscle, tendon, joint capsules, and even bone. This wavelength passes through water and hemoglobin more efficiently than red light, allowing deeper tissue penetration. The 810nm wavelength is particularly well-studied for musculoskeletal conditions and is also the primary wavelength used in transcranial photobiomodulation for neurological applications. 850nm is another well-researched wavelength with excellent tissue penetration.

Many clinical protocols and home devices use a combination of both wavelengths to address both superficial and deeper tissue simultaneously. The dose (measured in joules per square centimeter, or J/cm2) is critical – too little energy produces no effect, while too much can actually inhibit cellular function (this is called the biphasic dose response or Arndt-Schulz principle).

Three Core Therapeutic Effects

What the Evidence Shows: Condition by Condition

Musculoskeletal Pain – ESTABLISHED (FDA-Cleared)

This is LLLT’s strongest and most widely recognized indication. The FDA has cleared multiple Class II laser devices for the temporary relief of minor muscle and joint pain, arthritis, muscle spasm, and stiffness. Multiple systematic reviews and meta-analyses support its effectiveness for chronic neck pain, low back pain, knee osteoarthritis, and various tendinopathies. A 2015 Lancet meta-analysis of 22 RCTs found that LLLT significantly reduced pain and disability in chronic joint disorders when appropriate doses were used. The World Association for Photobiomodulation Therapy (WALT) has published dosing guidelines for specific musculoskeletal conditions. Key finding from the research: dosing matters enormously – studies using inadequate energy densities often show no effect, which has historically muddied the evidence base.

Oral Mucositis – ESTABLISHED

One of LLLT’s most well-established applications is the prevention and treatment of oral mucositis – the painful mouth sores that develop in many cancer patients undergoing chemotherapy or radiation to the head and neck. The Multinational Association of Supportive Care in Cancer (MASCC) and the International Society for Oral Oncology (ISOO) have included LLLT in their clinical practice guidelines, recommending it for mucositis prevention. Multiple high-quality RCTs demonstrate that LLLT significantly reduces the incidence, severity, and duration of mucositis, with some studies showing a reduction from grade 3-4 (severe) to grade 0-1 (mild or none). This application alone has brought photobiomodulation into mainstream oncology supportive care.

Wound Healing – PROMISING

LLLT has shown consistent positive results for accelerating wound healing, particularly in chronic and difficult-to-heal wounds such as diabetic ulcers, venous ulcers, and pressure sores. The mechanism involves accelerated fibroblast activity, increased collagen deposition, enhanced angiogenesis, and modulation of the inflammatory environment. A 2018 systematic review found that PBM significantly accelerated wound closure in diabetic foot ulcers. While the evidence is strong, it hasn’t quite reached the level of universal guideline inclusion for wound care – partly because of heterogeneity in protocols across studies. The direction of the evidence, however, is clearly positive.

Hair Loss (Androgenetic Alopecia) – PROMISING (FDA-Cleared Devices)

Several LLLT devices for hair regrowth have received FDA 510(k) clearance, including laser caps, helmets, and combs. The proposed mechanism involves stimulating hair follicle stem cells, increasing blood flow to the scalp, extending the anagen (growth) phase of the hair cycle, and reducing inflammation around follicles. Clinical trials have demonstrated statistically significant increases in hair density and thickness compared to sham devices, with both men and women showing benefit. A 2014 meta-analysis of 11 studies found that LLLT produced a significant increase in hair density. Results are modest compared to finasteride or hair transplantation but meaningful for many patients – and the safety profile is excellent. Devices typically use 650-670nm wavelengths and require consistent daily use (15-30 minutes) for 4-6 months before results become apparent.

Traumatic Brain Injury and Neurological Conditions – PROMISING (Transcranial PBM)

One of the most exciting frontiers for photobiomodulation is transcranial application – shining near-infrared light (typically 810nm) through the skull to reach cortical brain tissue. NIR photons can penetrate the skull (approximately 2-3% of surface energy reaches the brain), and the mechanism is the same: boosting mitochondrial ATP production in neurons that are metabolically compromised. Preliminary clinical trials in TBI, stroke recovery, Alzheimer’s disease, and Parkinson’s disease have shown promising results in cognitive function, mood, and neurological symptoms. A 2020 pilot study at Massachusetts General Hospital showed significant improvements in cognitive function in patients with chronic TBI treated with transcranial PBM. This is still an emerging field, but the mechanistic rationale is strong and the safety profile is excellent.

Depression – EARLY RESEARCH

Transcranial PBM targeting the prefrontal cortex has shown intriguing preliminary results for major depression. The rationale is that depression involves prefrontal cortical hypofunction and mitochondrial dysfunction, both of which PBM may address. Several small randomized trials have reported significant improvements in depression scores compared to sham treatment. However, the studies are small, and the field is early. Worth watching closely, but not yet sufficient to recommend as a standalone treatment for depression.

Clinical LLLT vs. At-Home Devices vs. Red Light Panels

The consumer market for light therapy devices has exploded, and navigating the options can be confusing. Here’s how the different categories compare:

Safety Profile

One of LLLT’s greatest strengths is its safety profile. When used at appropriate parameters, photobiomodulation has an excellent safety record with minimal side effects. The light is non-thermal at therapeutic doses – it does not heat tissue (hence “cold laser”), does not cause burns, and does not damage DNA. This stands in contrast to high-power surgical or ablative lasers, which are entirely different devices with different mechanisms.

Cost and Practical Considerations

Clinical LLLT sessions typically cost $50-$200 per session, with most treatment protocols calling for 2-3 sessions per week over 4-8 weeks (total: $400-$4,800 for a full course). Some physical therapy clinics include LLLT as part of a broader treatment session at no additional charge.

Home devices represent a significant alternative for ongoing use. Laser caps for hair loss ($400-$1,500), handheld cold laser devices ($200-$800), and full-body red light panels ($300-$2,000) allow for daily home treatment at a one-time investment. The trade-off is lower power (longer treatment times needed) and less clinical guidance on targeting and dosing.

Insurance coverage for LLLT varies. It’s most commonly covered when provided as part of a physical therapy visit for musculoskeletal conditions. Standalone LLLT sessions are less frequently covered. FDA clearance of devices for specific conditions (pain, hair loss) supports the case for coverage but doesn’t guarantee it. Check with your insurer and ask your provider about the CPT codes they use for billing.

Frequently Asked Questions

Can I feel anything during LLLT treatment?

Generally, no – which is why it’s called “cold laser.” Unlike high-power surgical lasers that cut and burn, LLLT operates at energy levels that produce no perceptible heat or sensation in most cases. Some patients report a mild warming sensation with higher-power Class IV therapeutic lasers, and occasionally people feel a slight tingling in the treatment area. But the absence of sensation doesn’t mean nothing is happening – the biological effects are occurring at the cellular and molecular level, below the threshold of conscious perception.

How long until I see results?

This varies significantly by condition. For acute musculoskeletal pain, some patients notice improvement after 1-3 sessions. For chronic conditions, meaningful results typically emerge after 6-10 sessions (2-4 weeks of treatment). For hair regrowth, expect 4-6 months of consistent daily use before visible results. Neurological applications (transcranial PBM) may require 12-24 sessions over several weeks. The key is consistency – the biological effects of photobiomodulation are cumulative, building on each other with repeated sessions.

What’s the difference between LLLT and high-power laser therapy?

Power level and mechanism. LLLT uses low-power lasers (typically under 500mW) that produce photochemical effects – stimulating cellular processes without generating significant heat. High-power laser therapy (HPLT, sometimes called Class IV laser therapy) uses lasers at 1-60+ watts and produces both photochemical and photothermal effects. HPLT can deliver energy to deeper tissues faster, but the thermal component raises different safety considerations. Some practitioners prefer HPLT for its speed and depth; others prefer the gentler, more purely photochemical approach of LLLT. Both have clinical evidence, and the optimal choice depends on the condition and treatment goals.

Are red light therapy panels legitimate, or just a wellness fad?

Both, depending on the specific panel and the specific claim. Quality red/NIR LED panels from reputable manufacturers (Joovv, Biolight, PlatinumLED) deliver wavelengths and energy densities that fall within the therapeutic range demonstrated in research. The underlying mechanism is the same regardless of whether the photons come from a laser or an LED. However, many cheap panels on Amazon use wavelengths, power levels, or irradiance that are insufficient for therapeutic benefit. And many wellness marketing claims (anti-aging miracles, fat loss, etc.) outpace the evidence. A quality panel used at appropriate distance and duration can deliver real photobiomodulation effects to superficial tissue – just verify the specs match the published research.

Can LLLT help with arthritis?

Yes, with caveats. LLLT has good evidence for reducing pain and improving function in osteoarthritis, particularly of the knee and hand. It works by reducing inflammation in the joint capsule and surrounding tissue, not by regenerating cartilage. So it manages the condition effectively but isn’t reversing the underlying structural damage. For rheumatoid arthritis, LLLT can help reduce pain and morning stiffness, though the systemic nature of the disease means it should complement – not replace – disease-modifying medications. A 2015 Cochrane review found low to moderate evidence that LLLT reduces pain and disability in RA of the hand.

Is more light always better?

No – and this is a critical point that many home users miss. Photobiomodulation follows a biphasic dose response (the Arndt-Schulz principle): too little energy produces no effect, an optimal dose produces the maximum therapeutic effect, and too much energy can actually inhibit cellular function or cause harm. This means blasting yourself with the maximum power for the longest possible time is counterproductive. Follow the dosing guidelines specific to your condition, and when in doubt, less is more. Clinical research typically uses 1-4 J/cm2 for superficial tissue and 4-8 J/cm2 for deeper structures.

The Bottom Line

Laser therapy and photobiomodulation represent one of the most scientifically grounded yet underappreciated tools in regenerative and integrative medicine. The mechanism – light stimulating mitochondrial function to boost cellular energy and activate repair pathways – is well-established at the molecular level. The clinical evidence is strong for musculoskeletal pain and oral mucositis, promising for wound healing, hair loss, and neurological applications, and growing across new areas of research.

The biggest barriers to broader adoption have been inconsistent dosing in early research (which produced mixed results and skepticism), the flood of low-quality consumer devices making unsubstantiated claims, and a name – “cold laser” – that frankly sounds like science fiction. But the science is real, the evidence is substantial, and the safety profile is excellent. Whether through clinical treatment or a quality home device, photobiomodulation deserves a place in the conversation about evidence-based approaches to pain, healing, and cellular health.

Related Topics

Explore related therapies and conditions on Regenerated:

• Red Light Therapy – A focused look at LED-based red and near-infrared light panels for skin health, recovery, and whole-body wellness
• Stem Cell Therapy – How regenerative medicine uses your body’s own repair cells and where the evidence stands
• Chronic Pain – Integrative approaches to persistent pain that go beyond medication management
• Traumatic Brain Injury – Understanding brain injury recovery and emerging therapies including transcranial photobiomodulation